GCM
ABBV icon

Gallacher Capital Management’s AbbVie ABBV Stock Holding History

Gallacher Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,091
Closed -$237K – 260
2026
Q1 		$237K Sell
1,091
-15
-1% -$3.33K 0.09% 267
2025
Q4 		$253K Hold
1,106
– – 0.1% 258
2025
Q3 		$256K Sell
1,106
-1,250
-53% -$255K 0.1% 266
2025
Q2 		$437K Buy
2,356
+1,274
+118% +$237K 0.2% 147
2025
Q1 		$227K Sell
1,082
-1,125
-51% -$219K 0.11% 240
2024
Q4 		$392K Sell
2,207
-34
-2% -$6.25K 0.19% 140
2024
Q3 		$443K Sell
2,241
-21
-0.9% -$3.92K 0.2% 124
2024
Q2 		$388K Sell
2,262
-45
-2% -$7.45K 0.2% 135
2024
Q1 		$420K Sell
2,307
-52
-2% -$8.96K 0.21% 121
2023
Q4 		$366K Sell
2,359
-209
-8% -$30.5K 0.2% 127
2023
Q3 		$383K Buy
2,568
+465
+22% +$68.3K 0.24% 96
2023
Q2 		$283K Sell
2,103
-29
-1% -$4.25K 0.16% 180
2023
Q1 		$340K Buy
2,132
+799
+60% +$122K 0.2% 134
2022
Q4 		$215K Buy
+1,333
New +$204K 0.13% 211

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gallacher Capital Management's ABBV Position: Q2 2026 in Review

Gallacher Capital Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,091 shares — an estimated $237K sold.

Gallacher Capital Management first reported a position in ABBV in Q4 2022 and held it in 14 quarters. The position peaked at $443K in Q3 2024. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Gallacher Capital Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Gallacher Capital Management sold 1,091 AbbVie shares in Q2 2026, an estimated $237K.
  • Gallacher Capital Management first reported a position in AbbVie in Q4 2022 and held it in 14 quarters.
  • Gallacher Capital Management's AbbVie position peaked at $443K in Q3 2024.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.